Europe Direct-to-Consumer (DTC) Genetic Testing Market (2025-2035)
The European direct-to-consumer genetic testing market is expected to reach $3.78 billion by 2035, growing from an estimated $464 million in 2025, at a CAGR of 23.3% during the forecast period of 2025-2035. Report Overview This report analyzes the European direct-to-consumer genetic testing market,
- Published
- May 2025
- Pages
- 165
- Format
- PDF + Excel
- Report ID
- MR-1501
- Base year
- 2024
- 2025 · ESTIMATED
- $464.0M
- 2035
- $3.78B
- CAGR 2025–2035
- 23.3%
2024 baseline · 2025–2035 forecast at 23.3% CAGR · hover a bar for the value
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | 165 |
| Format | PDF & Excel |
| Forecast Period | 2025-2035 |
| Base Year | 2024 |
| CAGR (Value) | 23.3% |
| Market Size (Value) in 2025 | $464 Million |
| Market Size (Value) in 2035 | $3.78 Billion |
| Segments Covered | By Test Type · Health & Disease Predisposition Testing · Nutrigenomics & Metabolism Testing · Physical Traits & Performance Testing · Pharmacogenetics · Skin, Aging, and Dermatogenetics · Food Intolerances & Sensitivities · Wellness & Lifestyle Testing · Ancestry & Lineage Testing · Other Tests · By Technology · DNA Microarrays · Next-generation Sequencing (NGS) · PCR-based Analysis · Others · By Sample Type · Saliva · Buccal (Cheek Swab) · Blood · Others · By Distribution Channel · Online Platforms · Pharmacies & Drugstores · Health Clinics & Laboratories · Hospitals · Direct Company Websites |
| Countries Covered | Germany, United Kingdom, France, Italy, Spain, Netherlands, Sweden, Denmark, Norway, Switzerland, Austria, Finland, Rest of Europe |
| Key Companies | 23andMe, Inc., Ancestry.com LLC, MyHeritage Ltd., Living DNA Ltd., Dante Labs S.r.l., tellmeGen S.L., Prenetics Global Limited, Chronomics Limited, GenePlanet d.o.o., ADNTRO Genetics S.L., LetsGetChecked Ltd., Veritas Genetics, Inc. |
Report overview
Segments covered: test type, technology, sample type.
This report analyzes the European direct-to-consumer genetic testing market, evaluating how companies are addressing the growing consumer interest in personalized health insights, increasing awareness of genetic predispositions, and evolving healthcare personalization requirements across European regions. The report provides a strategic analysis of market dynamics, growth projections till 2035, and competitive positioning across regional and country-level markets within Europe.
The European DTC genetic testing market is primarily driven by increasing consumer awareness about personalized medicine, growing interest in ancestry and genealogy research, rising prevalence of chronic diseases, and technological advancements in genomic sequencing. The shift towards comprehensive health and wellness testing panels and focus on user-friendly sample collection methods are reshaping the industry, while enhanced data privacy compliance and regulatory frameworks are gaining significant traction. Additionally, integration with digital health platforms and telemedicine services and the development of AI-powered genetic interpretation tools are further driving market growth, especially in developed European markets with advanced healthcare infrastructure.
-genetic-testing-market.webp)
Market dynamics
2 factors across 2 forcesThe European DTC genetic testing market
offers several high-growth opportunities. Development of pharmacogenetic testing for personalized medication selection is driving innovation across multiple segments. Another major opportunity lies in expanding partnerships with healthcare providers and integration into routine medical care. Additionally, growing focus on preventive healthcare and wellness optimization, along with increasing adoption of multi-omics approaches combining genomics with other biological data, are creating new revenue streams for solution providers as consumers increasingly seek comprehensive health insights.
Table of contents
12 chapters · 95 sections · 165 pages · click to expandGeographic analysis
Europe
Largest shareGermany is expected to hold the largest share of the European DTC genetic testing market in 2025, driven by advanced healthcare infrastructure, high consumer awareness about genetic testing, and significant investments in personalized medicine research. Additionally, favorable regulatory environment and strong biotechnology sector contribute significantly to market dominance. The U.K. follows as the second-largest market, bolstered by established genetic research institutions and high adoption of digital health technologies. However, the Netherlands and Nordic countries (Sweden, Denmark, Norway) are witnessing rapid growth rates during the forecast period, primarily driven by progressive healthcare policies, high digital literacy, growing focus on preventive healthcare, and strong government support for genomic medicine initiatives.
Competitive landscape
The European direct-to-consumer genetic testing market features a diverse competitive landscape with established genetic testing companies, biotechnology specialists, digital health solution providers, and innovative genomics startups pursuing varied approaches to consumer genetic testing implementation.
The broader competitive landscape is categorized into industry leaders, market differentiators, vanguards, and contemporary stalwarts, with each group employing distinctive strategies to maintain competitive advantage. Leading providers are focusing on comprehensive testing panels that combine multiple genetic insights with personalized health recommendations while addressing region-specific regulatory requirements and privacy concerns.
The key players operating in the European DTC genetic testing market include 23andMe, Inc., Ancestry.com LLC, MyHeritage Ltd., Living DNA Ltd., Dante Labs S.r.l., tellmeGen S.L., Prenetics Global Limited, Chronomics Limited, GenePlanet d.o.o., ADNTRO Genetics S.L., LetsGetChecked Ltd., Veritas Genetics, Inc., and several other regional and emerging players focusing on specialized genetic testing applications.
- 23andMe, Inc.
- Ancestry.com LLC
- MyHeritage Ltd.
- Living DNA Ltd.
- Dante Labs S.r.l
- Prenetics Global Limited
- Chronomics Limited
- GenePlanet d.o.o
- ADNTRO Genetics S.L
- LetsG
Frequently asked questions
The European DTC genetic testing market is expected to reach $3.78 billion by 2035, growing from an estimated $464 million in 2025, at a CAGR of 23.3% during the forecast period of 2025-2035.
Cite this report
Meticulous Research. (2025). Europe Direct-to-Consumer (DTC) Genetic Testing Market - Opportunity Analysis And Industry Forecast (2025-2035) (Report No. MR-1501). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/reports/europe-direct-to-consumer-genetic-testing-market-6184